NM_170707.4:c.94A>G
Variant summary
Our verdict is Pathogenic. Variant got 17 ACMG points: 17P and 0B. PM1PM2PM5PP2PP3_ModeratePP5_Very_Strong
The NM_170707.4(LMNA):c.94A>G(p.Lys32Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K32T) has been classified as Pathogenic.
Frequency
Consequence
NM_170707.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LMNA | NM_170707.4 | c.94A>G | p.Lys32Glu | missense_variant | Exon 1 of 12 | ENST00000368300.9 | NP_733821.1 | |
LMNA | NM_005572.4 | c.94A>G | p.Lys32Glu | missense_variant | Exon 1 of 10 | ENST00000677389.1 | NP_005563.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LMNA | ENST00000368300.9 | c.94A>G | p.Lys32Glu | missense_variant | Exon 1 of 12 | 1 | NM_170707.4 | ENSP00000357283.4 | ||
LMNA | ENST00000677389.1 | c.94A>G | p.Lys32Glu | missense_variant | Exon 1 of 10 | NM_005572.4 | ENSP00000503633.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease type 2 Pathogenic:1
This sequence change replaces lysine, which is basic and polar, with glutamic acid, which is acidic and polar, at codon 32 of the LMNA protein (p.Lys32Glu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with autosomal dominant LMNA-related neuromuscular conditions (PMID: 28688748, 32571898; Clinvar). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 476837). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt LMNA protein function. For these reasons, this variant has been classified as Pathogenic. -
Congenital muscular dystrophy due to LMNA mutation Pathogenic:1
The heterozygous p.Lys32Glu variant was identified by our study in one individual with congenital muscular dystrophy. Trio exome analysis showed this variant to be de novo. This variant has been identified in the literature in one affected heterozygous proband (Monges et al. 2011). This variant was absent from large population studies. The Lysine (Lys) at position 32 is highly conserved in mammals and evolutionarily distant species, supporting that a change at this position may not be tolerated. Additionally, computational prediction tools suggest that this variant may impact the protein. A lab has reported this variant as likely pathogenic in Clinvar; however, the phenotype listed is Charcot-Marie-Tooth disease. In summary, although additional studies are required to fully establish its pathogenicity, this variant is likely pathogenic for congenital muscular dystrophy. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at